Senior Medical Director, Radiopharmaceuticals; HCC & GI
Listed on 2026-10-03
-
Healthcare
Oncology Care, Healthcare Consultant
Rayze Bio, a wholly-owned subsidiary of Bristol Myers Squibb, seeks a Sr Medical Director, Clinical Development in radiopharmaceuticals to oversee IND- through Phase 3 development for HCC and GI cancers. You will guide trial design, safety monitoring, and regulatory collaboration within a fast-growing biotech environment.
This role requires MD with oncology subspecialty and 5+ years in pharma/biotech oncology development, with a focus on radiopharmaceuticals preferred. Travel ~30% is expected.
This Full Time opening is for the Senior Medical Director, Radiopharmaceuticals (HCC & GI) role at Bristol Myers Squibb.
Please review the full job details above before applying.
If your experience matches this role, we encourage you to apply.
All applications are reviewed carefully by our team.
This is a Full Time role.
The position is based in United States.
This opportunity is part of our work in Bio & Pharmacology & Health.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).